Precision Payload: ADCs for Solid Tumors and the Essential Role of Oncology Pharmacists in TRAE Identification and Management

With increasing use of antibody–drug conjugates (ADCs) for the treatment of various tumor types, it is important to know how to manage treatment-related adverse events (TRAEs). Learners will be able to identify and manage TRAEs, tailor individual treatment plans, and discuss the mechanisms by which ADCs contribute to different safety profiles.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by ProCE, LLC in collaboration with Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner